Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate versus propofol for general anesthesia in outpatient surgery
ChiCTR2100048904Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2021
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam, propofol and flumazenil (3 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Anesthesia induction time and Anesthesia recovery time. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
remimazolampropofolflumazenil
Beyond the preview
Go deeper on ChiCTR2100048904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048904.